# Evaluation of bioMarkErs to Reduce Antibiotics Use in hospitalizeD nEonates

> **NCT03299751** · NA · COMPLETED · sponsor: **Hospices Civils de Lyon** · enrollment: 233 (actual)

## Conditions studied

- Late-Onset Neonatal Sepsis

## Interventions

- **BIOLOGICAL:** Diagnostic performances of biomarkers combination

## Key facts

- **NCT ID:** NCT03299751
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-22
- **Primary completion:** 2020-11-20
- **Final completion:** 2020-11-20
- **Target enrollment:** 233 (ACTUAL)
- **Last updated:** 2025-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03299751

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03299751, "Evaluation of bioMarkErs to Reduce Antibiotics Use in hospitalizeD nEonates". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03299751. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*